Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/22 16:35 | 1/11/22 | CRBU | Health | BioPrd | Biological Products, (No Diag | Fischesser Ryan | CA | O | VP of Fi | P.d | 30 | 4.00 | 0 | 7 | 7 | 109 | D | ||||||||||||||
12/21/21 17:23 | 12/20/21 | CRBU | Health | BioPrd | Biological Products, (No Diag | Fischesser Ryan | CA | O | VP of Fi | P.d | 3 | 2.69 | 0 | 1 | 1 | 102 | D | ||||||||||||||
12/8/21 18:06 | 12/7/21 | CRBU | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | P.d | 16 | 2.69 | 0 | 6 | 2 | 349 | D | ||||||||||||||
10/21/21 18:12 | 10/20/21 | CRBU | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | P.d | 25 | 2.69 | 0 | 9 | 3 | 343 | D | ||||||||||||||
10/13/21 19:31 | 10/12/21 | CRBU | Health | BioPrd | Biological Products, (No Diag | Kanner Steven | CA | O | Chief Sc | P.d | 221 | 1.92 | 0 | 115 | 115 | 215 | D | ||||||||||||||
10/12/21 19:33 | 10/11/21 | CRBU | Health | BioPrd | Biological Products, (No Diag | Fischesser Ryan | CA | O | VP of Fi | P.d | 5 | 2.69 | 0 | 2 | 2 | 101 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |